These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3971369)

  • 1. Cytotoxicity of the alkyl-linked lipoidal amine 4-aminomethyl-1-[2,3-(di-n-decyloxy)-n-propyl]-4-phenylpiperidine (CP-46,665) in cells from human tumors and leukemias.
    Berdel WE; Schick HD; Fink U; Reichert A; Ulm K; Rastetter J
    Cancer Res; 1985 Mar; 45(3):1206-13. PubMed ID: 3971369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of thioether-lysophospholipids in leukemias and tumors of human origin.
    Berdel WE; Fromm M; Fink U; Pahlke W; Bicker U; Reichert A; Rastetter J
    Cancer Res; 1983 Nov; 43(11):5538-43. PubMed ID: 6577950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of alkyl-lysophospholipid derivatives and low-alkyl-cleavage enzyme activities in rat brain tumor cells.
    Berdel WE; Greiner E; Fink U; Stavrou D; Reichert A; Rastetter J; Hoffman DR; Snyder F
    Cancer Res; 1983 Feb; 43(2):541-5. PubMed ID: 6848177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of leukemic cells by the combined use of ether lipids in vitro.
    Okamoto S; Olson AC; Vogler WR
    Cancer Res; 1987 May; 47(10):2599-603. PubMed ID: 3471316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-cytotoxicity studies on alkyl lysophospholipids and some analogs in leukemic blasts of human origin in vitro.
    Danhauser S; Berdel WE; Schick HD; Fromm M; Reichert A; Fink U; Busch R; Eibl H; Rastetter J
    Lipids; 1987 Nov; 22(11):911-5. PubMed ID: 3444384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
    Schick HD; Berdel WE; Fromm M; Fink U; Jehn U; Ulm K; Reichert A; Eibl H; Unger C; Rastetter J
    Lipids; 1987 Nov; 22(11):904-10. PubMed ID: 3444383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some antagonists of platelet activating factor are cytotoxic for human malignant cell lines.
    Danhauser-Riedl S; Felix SB; Houlihan WJ; Zafferani M; Steinhauser G; Oberberg D; Kalvelage H; Busch R; Rastetter J; Berdel WE
    Cancer Res; 1991 Jan; 51(1):43-8. PubMed ID: 1988103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineoplastic activity of the thioether lysophospholipid derivative BM 41.440 in vitro.
    Fromm M; Berdel WE; Schick HD; Fink U; Pahlke W; Bicker U; Reichert A; Rastetter J
    Lipids; 1987 Nov; 22(11):916-8. PubMed ID: 3444385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
    Unger C; Eibl H; Kim DJ; Fleer EA; Kötting J; Bartsch HH; Nagel GA; Pfizenmaier K
    J Natl Cancer Inst; 1987 Feb; 78(2):219-22. PubMed ID: 3468284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antiproliferative activity of combinations of ether lipid analogues and DNA-interactive agents against human tumor cells.
    Noseda A; Berens ME; White JG; Modest EJ
    Cancer Res; 1988 Apr; 48(7):1788-91. PubMed ID: 3349458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human tumor colony formation by the new alkyl lysophospholipid ilmofosine.
    Neumann HA; Herrmann DB; Boerner D
    J Natl Cancer Inst; 1987 Jun; 78(6):1087-93. PubMed ID: 3473249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of alkyl-lysophospholipids on tritiated thymidine incorporation and clonogenicity in vitro of normal and leukemic human cells.
    Vogler WR; Whigham EA; Somberg LB; Long RC; Winton EF
    Exp Hematol; 1984 Aug; 12(7):569-74. PubMed ID: 6540197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro.
    Storme GA; Berdel WE; van Blitterswijk WJ; Bruyneel EA; De Bruyne GK; Mareel MM
    Cancer Res; 1985 Jan; 45(1):351-7. PubMed ID: 4038380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species.
    Wagner BA; Buettner GR; Oberley LW; Burns CP
    Cancer Res; 1998 Jul; 58(13):2809-16. PubMed ID: 9661895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ether lipid derivatives: antineoplastic activity in vitro and the structure-activity relationship.
    Berdel WE; Von Hoff DD; Unger C; Schick HD; Fink U; Reichert A; Eibl H; Rastetter J
    Lipids; 1986 Apr; 21(4):301-4. PubMed ID: 3713449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivatives of benzo(c)fluorene. XXIV. Cytostatic effect of benfluron on human leukemic cells in vitro.
    Soucek J; Stöckbauer P; Mĕlka M; Koubek K; Chudomel V; Krepelka J
    Neoplasma; 1987; 34(1):45-54. PubMed ID: 3561605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of therapeutic activity of the lipoidal amine CP-46,665 in rodent tumors and human non-seminomatous germ cell tumors growing in nude mice.
    Berdel WE; Berger MR; Falk H; Harstrick A; Danhauser S; Schick HD; Schmoll HJ; Schmähl D; Vogler WR; Rastetter J
    Cancer Lett; 1987 Dec; 38(1-2):191-7. PubMed ID: 2825966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic effects of alkyl-lysophospholipids in human brain tumor cells.
    Berdel WE; Greiner E; Fink U; Zänker KS; Stavrou D; Trappe A; Fahlbusch R; Reichert A; Rastetter J
    Oncology; 1984; 41(2):140-5. PubMed ID: 6709277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed function oxidase activities of established human colon carcinoma cell lines in the activation of cyclophosphamide.
    Moskwa PS; Vadi H; Drewinko B
    Cancer Res; 1985 Nov; 45(11 Pt 1):5447-51. PubMed ID: 4053018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.